LMR Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 851 |
|
|
2025
Q1 | – | Sell |
-4,418
| Closed | -$290K | – | 923 |
|
|
2024
Q4 | $290K | Sell |
4,418
-70,730
| -94% | -$4.65M | ﹤0.01% | 534 |
|
|
2024
Q3 | $5.28M | Sell |
75,148
-47,969
| -39% | -$3.37M | 0.04% | 185 |
|
|
2024
Q2 | $10.1M | Buy |
123,117
+44,917
| +57% | +$3.7M | 0.09% | 124 |
|
|
2024
Q1 | $6.83M | Hold |
78,200
| – | – | 0.07% | 129 |
|
|
2023
Q4 | $7.54M | Buy |
78,200
+1,835
| +2% | +$177K | 0.09% | 139 |
|
|
2023
Q3 | $6.76M | Buy |
76,365
+41,354
| +118% | +$3.66M | 0.08% | 148 |
|
|
2023
Q2 | $3.03M | Sell |
35,011
-39,408
| -53% | -$3.42M | 0.03% | 219 |
|
|
2023
Q1 | $7.24M | Buy |
74,419
+17,494
| +31% | +$1.7M | 0.11% | 193 |
|
|
2022
Q4 | $5.89M | Buy |
56,925
+2,040
| +4% | +$211K | 0.1% | 227 |
|
|
2022
Q3 | $4.65M | Buy |
54,885
+18,932
| +53% | +$1.61M | 0.09% | 279 |
|
|
2022
Q2 | $2.98M | Sell |
35,953
-54,650
| -60% | -$4.53M | 0.05% | 409 |
|
|
2022
Q1 | $6.99M | Buy |
90,603
+55,448
| +158% | +$4.27M | 0.08% | 251 |
|
|
2021
Q4 | $3.11M | Buy |
+35,155
| New | +$3.11M | 0.03% | 341 |
|
|
2021
Q3 | – | Sell |
-7,895
| Closed | -$659K | – | 1004 |
|
|
2021
Q2 | $659K | Hold |
7,895
| – | – | 0.01% | 628 |
|
|
2021
Q1 | $596K | Sell |
7,895
-20,605
| -72% | -$1.56M | 0.01% | 597 |
|
|
2020
Q4 | $2.5M | Buy |
+28,500
| New | +$2.5M | 0.04% | 178 |
|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$539K | – | 408 |
|
|
2019
Q3 | $539K | Buy |
+8,000
| New | +$539K | 0.03% | 252 |
|